Search Press releases Keywords From To 18 Mar 2023 Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and Maintained Response over 48 Weeks Read More 17 Mar 2023 Acquisition of own shares Read More 16 Mar 2023 UCB to Present Eight Bimekizumab Abstracts at AAD 2023 with Results from Studies in Psoriasis, Psoriatic Arthritis and Hidradenitis Suppurativa Read More 15 Mar 2023 Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease Read More 10 Mar 2023 Acquisition of own shares Read More 9 Mar 2023 Cancer Research UK Signs Multi-Project Collaboration With UCB To Advance Oncology Antibody Candidates Read More Pagination First page Previous page Previous … Page 25 Page 26 Page 27 Page 28 Current page 29 Page 30 Page 31 Page 32 Page 33 … Page 29 of 70 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
